Avecho Biotechnology Ltd has released a press release.
Terumo Shifts Focus From Oxymorphone Patch to Injectables
Filed with ASX ·
6ix hasn’t read this filing yet.
Avecho Biotechnology Limited on 6ix
Story so far
Earlier from Avecho Biotechnology
- Preliminary Final Report
- Phosphagenics Placement Secures A$1.37 million
- Phosphagenics Receipt of R&D Tax Incentive
- Phosphagenics Announces Results of Dairy Trial
- TPM Improves Negative Effects of Heat Stress in Poultry
Later from Avecho Biotechnology
- AGM Chairmans Address and CEO Presentation
- Half Year Accounts
- Phosphagenics Licensing Agreement Update
- Phosphagenics Receives Further Arbitration Process Update
- Phosphagenics Arbitration Award Issued
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology